Cempra Holdings (CEMP) Releases Quarterly Earnings, Misses Estimates By $0.09 EPS
Cempra Holdings (NASDAQ:CEMP) released its earnings data on Thursday. The company reported ($0.51) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.42) by $0.09, Analyst Ratings.Net reports. The company had revenue of $2.07 million for the quarter, compared to the consensus estimate of $1.25 million. During the same quarter last year, the company posted ($0.27) earnings per share. Cempra Holdings’s revenue was up 4046.0% compared to the same quarter last year.
Several analysts have recently commented on the stock. Analysts at Jefferies Group reiterated a “buy” rating on shares of Cempra Holdings in a research note on Tuesday, December 17th. Finally, analysts at Robert W. Baird initiated coverage on shares of Cempra Holdings in a research note on Wednesday, December 11th. They set an “outperform” rating and a $21.00 price target on the stock. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $16.00.
Shares of Cempra Holdings (NASDAQ:CEMP) traded up 0.15% during mid-day trading on Thursday, hitting $12.97. The stock had a trading volume of 226,128 shares. Cempra Holdings has a one year low of $5.97 and a one year high of $15.39. The stock has a 50-day moving average of $13.09 and a 200-day moving average of $11.56. The company’s market cap is $430.5 million.
Cempra, Inc, formerly Cempra Holdings, LLC, is a development-stage and clinical-stage pharmaceutical company focused on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic and acute staphylococcal infections.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.